BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization

Summary

Patients with mild and severe COVID 19 will be randomized 1:1 into two groups: experimental, which will get bromhexine and spironolactone, and control. Patients will get investigated therapy for ten days. Change in clinical assessment score COVID 19 (CAS COVID 19) between baseline and 12th day will be evaluated as a primary endpoint. Forty-five-day risk of death or mechanical ventilation will also be assessed.

Timeline

Start

2020-05-16

Primary completion

2020-07-18

Completion

2020-08-23

Drugs

Indications